Jacqueline will take up the new role in addition to her current role as Chief Executive of St George’s University Hospitals NHS Foundation Trust. 

We are pleased to announce that Jacqueline Totterdell, Chief Executive of St George’s University Hospitals NHS Foundation Trust, has been appointed Chair of the Clinical Research Network (CRN) South London Partnership Board.

CRN South London is part of the National Institute for Health Research and helps to increase opportunities for patients to take part in clinical research, which will lead to better treatments now and in the future.

The CRN South London partnership board, which meets three times a year, provides active oversight and constructive mutual challenge on CRN plans, activities, performance and reports in order to support the CRN to achieve its objectives and raise the ambitions for clinical research.

The role of Chair is a voluntary position which Jacqueline will take up in addition to her role as Chief Executive at St George’s. She will chair her first board meeting in December 2019.

Jacqueline Totterdell said: “I am delighted to have been appointed to this role with CRN South London. Clinical research is vital to the development of the treatments of tomorrow that will make such a difference to patients.

“Along with our Medical staff, Nurses and Allied Health Professionals also make a huge contribution in this area, and I hope we can encourage even more of them to get involved with shaping the future of clinical research.

“At St George’s, we pride ourselves on our commitment to research with more clinical trials undertaken during 2017/18 than ever before. I’m looking forward to working closely with the CRN on their plans to develop clinical research across south London.”

CRN South London Chief Operating Officer Dr James Lyddiard said: “The team would like to welcome Jacqueline as the new chair of our Partnership Board.

“She has a well-established track record of championing research and fostering collaborative partnership working, which will be of immense value when working with the board to shape CRN South London’s strategic direction.”

In the last three years St George’s has grown its portfolio of research studies by 27%, placing us fourth nationally for increasing the number of clinical research studies we support.

Furthermore, one of the Trust’s priorities is to develop our strength in research, as outlined in our new five-year strategy.